Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-000167
Filing Date
2023-01-03
Accepted
2023-01-03 18:00:11
Documents
1
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3890
  Complete submission text file 0001493152-23-000167.txt   5193
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Silva Raul R. (Reporting) CIK: 0001883270 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40874 | Film No.: 23503623